Search Results

There are 9270 results for: content related to: Fludarabine, cyclophosphamide, and rituximab in patients with advanced, untreated, indolent B-cell nonfollicular lymphomas

  1. You have free access to this content
    Prognosis for fludarabine therapy of chronic lymphocytic leukaemia based on ex vivo drug response by DiSC assay

    British Journal of Haematology

    Volume 106, Issue 1, July 1999, Pages: 71–77, Andrew G. Bosanquet, Stephen A. Johnson and Sue M. Richards

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1365-2141.1999.01516.x

  2. You have free access to this content
    Guidelines on the diagnosis and management of chronic lymphocytic leukaemia

    British Journal of Haematology

    Volume 125, Issue 3, May 2004, Pages: 294–317, D. Oscier, C. Fegan, P. Hillmen, T. Illidge, S. Johnson, P. Maguire, E. Matutes and D. Milligan

    Version of Record online : 1 APR 2004, DOI: 10.1111/j.1365-2141.2004.04898.x

  3. You have free access to this content
    The role of fludarabine in the treatment of follicular and mantle cell lymphoma


    Volume 101, Issue 5, 1 September 2004, Pages: 883–893, Georg Lenz, Wolfgang Hiddemann and Martin Dreyling

    Version of Record online : 27 JUL 2004, DOI: 10.1002/cncr.20483

  4. You have free access to this content
    Peripheral blood stem cell (PBSC) mobilization and transplantation after fludarabine therapy in chronic lymphocytic leukaemia (CLL): a report of the European Blood and Marrow Transplantation (EBMT) CLL subcommittee on behalf of the EBMT Chronic Leukaemias Working Party (CLWP)

    British Journal of Haematology

    Volume 108, Issue 3, March 2000, Pages: 595–601, Michallet, Thiébaut, Dreger, Remes, Milpied, Santini, Hamon, Björkstrand, Kimby, Belhabri, Tanguy and Apperley

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2141.2000.01900.x

  5. Opportunistic pulmonary infections with fludarabine in previously treated patients with low-grade lymphoid malignancies: A role for pneumocystis carinii pneumonia prophylaxis

    American Journal of Hematology

    Volume 49, Issue 2, June 1995, Pages: 135–142, Dr. John C. Byrd, Jeffrey B. Hargis, Kent E. Kester, Duane R. Hospenthal, Sarah W. Knutson and Louis F. Diehl

    Version of Record online : 11 JUL 2006, DOI: 10.1002/ajh.2830490207

  6. You have free access to this content
    Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia


    Volume 118, Issue 2, 15 January 2012, Pages: 434–443, Alessandra Tedeschi, Giulia Benevolo, Marzia Varettoni, Marta L. Battista, Pier L. Zinzani, Carlo Visco, Vittorio Meneghini, Pietro Pioltelli, Stefano Sacchi, Francesca Ricci, Michele Nichelatti, Francesco Zaja, Mario Lazzarino, Umbero Vitolo and Enrica Morra

    Version of Record online : 5 JUL 2011, DOI: 10.1002/cncr.26303

  7. You have free access to this content
    Treatment of fludarabine-refractory chronic lymphocytic leukemia


    Volume 115, Issue 13, 1 July 2009, Pages: 2824–2836, Apostolia-Maria Tsimberidou and Michael J. Keating

    Version of Record online : 28 APR 2009, DOI: 10.1002/cncr.24329

  8. You have free access to this content
    Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment

    American Journal of Hematology

    Volume 90, Issue 5, May 2015, Pages: 446–460, Michael Hallek

    Version of Record online : 23 APR 2015, DOI: 10.1002/ajh.23979

  9. Therapeutic potential of purine analogue combinations in the treatment of lymphoid malignancies

    Hematological Oncology

    Volume 18, Issue 4, December 2000, Pages: 141–153, S. A. Johnson and W. Thomas

    Version of Record online : 19 DEC 2000, DOI: 10.1002/1099-1069(200012)18:4<141::AID-HON666>3.0.CO;2-#

  10. You have free access to this content
    Fludarabine and mitoxantrone for patients with chronic lymphocytic leukemia


    Volume 100, Issue 12, 15 June 2004, Pages: 2583–2591, Apostolia M. Tsimberidou, Michael J. Keating, Francis J. Giles, William G. Wierda, Alessandra Ferrajoli, Susan Lerner, Miloslav Beran, Michael Andreeff, Hagop M. Kantarjian and Susan O'Brien

    Version of Record online : 6 MAY 2004, DOI: 10.1002/cncr.20264

  11. Antitumor activity of fludarabine against human multiple myeloma in vitro and in vivo

    European Journal of Haematology

    Volume 79, Issue 6, December 2007, Pages: 486–493, Haitao Meng, Chunmei Yang, Wanmao Ni, Wei Ding, Xiudi Yang and Wenbin Qian

    Version of Record online : 15 SEP 2007, DOI: 10.1111/j.1600-0609.2007.00968.x

  12. Chronic Lymphocytic Leukemia (CLL)

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 15 SEP 2006, DOI: 10.1002/9780470041000.cedt007

  13. You have full text access to this Open Access content
    Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma

    Cancer Science

    Volume 100, Issue 10, October 2009, Pages: 1951–1956, Kensei Tobinai, Ken-ichi Ishizawa, Michinori Ogura, Kuniaki Itoh, Yasuo Morishima, Kiyoshi Ando, Masafumi Taniwaki, Takashi Watanabe, Joji Yamamoto, Toshiki Uchida, Masanobu Nakata, Takashi Terauchi, Shigeru Nawano, Masaki Matsusako, Masaki Hayashi and Tomomitsu Hotta

    Version of Record online : 17 JUN 2009, DOI: 10.1111/j.1349-7006.2009.01247.x

  14. You have free access to this content
    A new model for predicting infectious complications during fludarabine-based combination chemotherapy among patients with indolent lymphoid malignancies


    Volume 101, Issue 9, 1 November 2004, Pages: 2042–2049, Constantine S. Tam, Max M. Wolf, E. Henry Januszewicz, Andrew P. Grigg, H. Miles Prince, David Westerman and John F. Seymour

    Version of Record online : 15 SEP 2004, DOI: 10.1002/cncr.20615

  15. You have full text access to this OnlineOpen article
    Severe fludarabine neurotoxicity after reduced intensity conditioning regimen to allogeneic hematopoietic stem cell transplantation: a case report

    Clinical Case Reports

    Volume 3, Issue 7, July 2015, Pages: 650–655, Claudio Annaloro, Antonella Costa, Nicola S Fracchiolla, Gabriella Mometto, Silvia Artuso, Giorgia Saporiti, Elena Tagliaferri, Federica Grifoni, Francesco Onida and Agostino Cortelezzi

    Version of Record online : 11 JUN 2015, DOI: 10.1002/ccr3.308

  16. You have free access to this content
    Cost-minimization analysis of CHOP, fludarabine and rituximab for the treatment of relapsed indolent B-cell non-Hodgkin's lymphoma in the U.K.

    British Journal of Haematology

    Volume 106, Issue 1, July 1999, Pages: 47–54, John Sweetenham, Klaus Hieke, Matthew Kerrigan, Paul Howard, Pamela F. M. Smartt, Ann-Marie McIntyre and Sarah Townshend

    Version of Record online : 20 APR 2002, DOI: 10.1046/j.1365-2141.1999.01515.x

  17. An investigation of fludarabine as a potential radiation sensitizer of human prostate cancer cells in vitro

    Asia-Pacific Journal of Clinical Oncology

    Volume 4, Issue 1, March 2008, Pages: 48–54, Anthony R BARNETSON, Christopher MILROSS and Pamela J RUSSELL

    Version of Record online : 10 MAR 2008, DOI: 10.1111/j.1743-7563.2008.00149.x

  18. You have free access to this content
    Synergism between fludarabine and rituximab revealed in a follicular lymphoma cell line resistant to the cytotoxic activity of either drug alone

    British Journal of Haematology

    Volume 114, Issue 4, September 2001, Pages: 800–809, N. Di Gaetano, Y. Xiao, E. Erba, R. Bassan, A. Rambaldi, J. Golay and M. Introna

    Version of Record online : 20 DEC 2001, DOI: 10.1046/j.1365-2141.2001.03014.x

  19. Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia

    Intervention Review

    The Cochrane Library

    Kathrin Bauer, Michaela Rancea, Verena Roloff, Thomas Elter, Michael Hallek, Andreas Engert and Nicole Skoetz

    Published Online : 14 NOV 2012, DOI: 10.1002/14651858.CD008079.pub2

  20. B-chronic lymphocytic leukemia: practical aspects

    Hematological Oncology

    Volume 20, Issue 3, September 2002, Pages: 103–146, Gerassimos A. Pangalis, Theodoros P. Vassilakopoulos, Maria N. Dimopoulou, Marina P. Siakantaris, Flora N. Kontopidou and Maria K. Angelopoulou

    Version of Record online : 26 APR 2002, DOI: 10.1002/hon.696